OPEN-LABEL, DOSE-ESCALATION, PHASE 1 STUDY OF SAFETY AND PHARMACOKINETICS OF DICHLOR-PHENAMIDE IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Cohen, F.
机构：
来源：
MUSCLE & NERVE | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
28
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [21] An Open-Label Dose-Escalation Study of Once-Daily and Twice-Daily Pasireotide in Healthy Volunteers: Safety, Tolerability, and Effects on Glucose, Insulin, and Glucagon Levels
    Shenouda, Magdy
    Maldonado, Mario
    Wang, Yanfeng
    Bouillaud, Emmanuel
    Hudson, Michelle
    Nesheiwat, Dalal
    Hu, Ke
    AMERICAN JOURNAL OF THERAPEUTICS, 2014, 21 (03) : 164 - 173
  • [22] A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
    Laties, Alan
    Rich, Cadmus C.
    Stoltz, Randall
    Humbert, Vernon
    Brickman, Chaim
    McVicar, William
    Baumgartner, Rudolf A.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (08) : 548 - 554
  • [23] Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
    Xianmin Meng
    Qianqian Wang
    Shunquan Wu
    Di Pu
    Amber Zhang
    Sun Fang
    Xuan Zhou
    Hongzhou Lu
    Rheumatology and Therapy, 2021, 8 : 1711 - 1724
  • [24] Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
    Meng, Xianmin
    Wang, Qianqian
    Wu, Shunquan
    Pu, Di
    Zhang, Amber
    Fang, Sun
    Zhou, Xuan
    Lu, Hongzhou
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1711 - 1724
  • [25] AN OPEN-LABEL DOSE-ESCALATION TRIAL OF ORAL DEHYDROEPIANDROSTERONE TOLERANCE AND PHARMACOKINETICS IN PATIENTS WITH HIV DISEASE
    DYNER, TS
    LANG, W
    GEAGA, J
    GOLUB, A
    STITES, D
    WINGER, E
    GALMARINI, M
    MASTERSON, J
    JACOBSON, MA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (05): : 459 - 465
  • [26] Open-label dose-escalation study of oral 1-octanol in patients with essential tremor
    Shill, HA
    Bushara, KO
    Mari, Z
    Reich, M
    Hallett, M
    NEUROLOGY, 2004, 62 (12) : 2320 - 2322
  • [27] Caffeine in Parkinson's disease: A pilot open-label, dose-escalation study
    Altman, Robert D.
    Lang, Anthony E.
    Postuma, Ronald B.
    MOVEMENT DISORDERS, 2011, 26 (13) : 2427 - 2431
  • [28] Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers - A phase I open-label study
    Lasseter, KC
    Dilzer, SC
    Vargas, R
    Waldman, S
    Noveck, RJ
    CLINICAL PHARMACOKINETICS, 2004, 43 (02) : 121 - 129
  • [29] A PHASE 1/2, OPEN-LABEL, DOSE-ESCALATION, SAFETY AND TOLERABILITY STUDY OF NC762 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS
    Myint, Han
    Shah, Satish
    Gutierrez, Martin
    Zsiros, Emese
    Nelson, Megan
    Zeidan, Stephanie
    Myrthil, Nadia
    Morawski, Aaron
    Barbu, Alina
    Shaik, Jahangheer
    Zhou, Chelsea
    Kanellopoulou, Chrysi
    Copeland, Ron
    Cusumano, Zachary
    Flies, Dallas
    Langermann, Solomon
    Lorusso, Patricia
    Odunsi, Kunle
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A781 - A781
  • [30] Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
    Kyriakopoulos, Christos
    Heath, Elisabeth I.
    Eickhoff, Jens C.
    Kolesar, Jill
    Yayehyirad, Mulusew
    Moll, Thomas
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345